BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16828016)

  • 1. [Selection of risk and diagnosis in diabetic polyneuropathy. Validation of method of new systems].
    Jurado J; Caula J; Pou i Torelló JM
    Aten Primaria; 2006 Jun; 38(2):116-21. PubMed ID: 16828016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study.
    Jurado J; Ybarra J; Romeo JH; Pou JM
    Eur J Clin Invest; 2009 Mar; 39(3):183-9. PubMed ID: 19260947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.
    Gylfadottir SS; Itani M; Krøigård T; Kristensen AG; Christensen DH; Nicolaisen SK; Karlsson P; Callaghan BC; Bennett DL; Andersen H; Tankisi H; Nielsen JS; Andersen NT; Jensen TS; Thomsen RW; Sindrup SH; Finnerup NB
    Eur J Neurol; 2020 Dec; 27(12):2575-2585. PubMed ID: 32909392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pedobarography - a novel screening tool for diabetic peripheral neuropathy?
    Fang F; Wang YF; Gu MY; Chen H; Wang DM; Xiao K; Yan S; Yao LL; Li N; Zhen Q; Peng YD
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3206-12. PubMed ID: 24338463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous oxygen pressure (TcPO₂): a novel diagnostic tool for peripheral neuropathy in type 2 diabetes patients.
    Deng W; Dong X; Zhang Y; Jiang Y; Lu D; Wu Q; Liang Z; Yang G; Chen B
    Diabetes Res Clin Pract; 2014 Sep; 105(3):336-43. PubMed ID: 25023217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes.
    Itani M; Gylfadottir SS; Krøigård T; Kristensen AG; Christensen DH; Karlsson P; Möller S; Andersen H; Tankisi H; Nielsen JS; Jensen TS; Thomsen RW; Finnerup NB; Sindrup SH
    J Peripher Nerv Syst; 2021 Mar; 26(1):55-65. PubMed ID: 33295647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients.
    Costa LA; Maraschin JF; Xavier de Castro JH; Gross JL; Friedman R
    Diabetes Res Clin Pract; 2006 Sep; 73(3):292-7. PubMed ID: 16564599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid screening of diabetic polyneuropathy: selection of accurate symptoms and signs in an outpatient clinical setting.
    Najafi L; Khamseh ME; Malek M; Baradaran HR; Aghili SM; Kia M; Aghili R
    Acta Med Iran; 2014; 52(7):519-27. PubMed ID: 25135261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
    Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
    J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark.
    Andersen ST; Grosen K; Tankisi H; Charles M; Andersen NT; Andersen H; Petropoulos IN; Malik RA; Jensen TS; Karlsson P
    J Diabetes Complications; 2018 Dec; 32(12):1153-1159. PubMed ID: 30309785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.
    Papanas N; Paschos P; Papazoglou D; Papatheodorou K; Paletas K; Maltezos E; Tsapas A
    Diabetes Care; 2011 Jun; 34(6):1378-82. PubMed ID: 21505209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
    Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
    J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.
    Sharma S; Vas PR; Rayman G
    J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
    Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J
    J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy.
    Hayashi Y; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Sasajima S; Asano-Hayami E; Motegi M; Asano S; Kato M; Nakai-Shimoda H; Tani H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Nakayama T; Nakamura J; Kamiya H
    J Diabetes Investig; 2024 Jun; 15(6):736-742. PubMed ID: 38421109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular autonomic neuropathy in patients with type 2 diabetes with and without sensorimotor polyneuropathy.
    Peters E; Itani M; Kristensen AG; Terkelsen AJ; Krøigård T; Tankisi H; Jensen TS; Finnerup NB; Gylfadottir SS
    J Peripher Nerv Syst; 2023 Sep; 28(3):450-459. PubMed ID: 37449440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: A cross-sectional Japanese study (JDDM 52) using a non-linear model.
    Yokoyama H; Tsuji T; Hayashi S; Kabata D; Shintani A
    J Diabetes Investig; 2020 Mar; 11(2):450-457. PubMed ID: 31314173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Random Forest Models to Identify Correlates of a Diabetic Peripheral Neuropathy Diagnosis from Electronic Health Record Data.
    DuBrava S; Mardekian J; Sadosky A; Bienen EJ; Parsons B; Hopps M; Markman J
    Pain Med; 2017 Jan; 18(1):107-115. PubMed ID: 27252307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).
    Cabezas-Cerrato J
    Diabetologia; 1998 Nov; 41(11):1263-9. PubMed ID: 9833931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.